Benchmark unveiled its FY21 results showing targets reached following a substantial reorganization of the company. 

“2021 was a very successful year for Benchmark with much accomplished financially, operationally and strategically. The group delivered a strong financial performance across its three business areas reflecting our new commercial focus and supported by improving conditions, particularly in our important shrimp market which had been hardest hit by the pandemic,” said Trond Williksen, CEO of Benchmark. “There is good momentum in our business helped by positive conditions in our markets contributing to a good start to the new financial year across all business areas, consistent with our outlook for the year as a whole.”

Advanced Nutrition reported revenue from continuing operations of £70.5 million, 19% ahead of FY20 driven by increased sales in the three product areas, Artemia, health and diets, with significant growth in Asia, India and Indonesia in particular, offsetting a drop in the Americas due to poor market conditions, particularly in Ecuador.

“The group delivered a strong financial performance across its three business areas reflecting our new commercial focus and supported by improving conditions, particularly in our important shrimp market which had been hardest hit by the pandemic,” said Peter George, Benchmark’s chairman. “We have a laid solid foundation  for our business with a clear strategy, financial discipline, culture and operational focus. Together with the good momentum, we are seeing in each of our business areas and the growing need in our markets for sustainable aquaculture solutions, which creates a positive outlook in the near and the long term. We remain focused on becoming profitable and on delivering profitable growth for our shareholders through disciplined investment.”